Lovastatin-d9

Lovastatin-d9 is intended for use as an internal standard for the quantification of lovastatin (Cay-10010338) by GC- or LC-MS. Lovastatin is a fungal metabolite that has been found in A. terreus and an inhibitor of HMG-CoA reductase (Ki = 1.4 nM). It is also a prodrug form of the HMG-CoA reductase inhibitor lovastatin hydroxy acid (Cay-10010339). Lovastatin (8 mg/kg per day) reduces plasma cholesterol levels in dogs. It suppresses TNF-induced NF-kappaB activation (IC50 = ~15 µM) and potentiates apoptosis in human myeloid leukemia cells. Lovastatin also increases cellular lipid peroxidation and decreases glutathione peroxidase 4 (GPX4) levels in cancer cells. Formulations containing lovastatin have been used in the treatment of hypercholesterolemia.Formal Name: 2S-(methyl-d3)-butanoic acid-2,3,3,4,4,4-d6, 1S,2,3R,7S,8S,8aR-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester. Molecular Formula: C24H27D9O5. Formula Weight: 413.6. Purity: >99% deuterated forms (d1-d9). Formulation: (Request formulation change), A solid. Solubility: Chloroform: slightly soluble, Methanol: slightly soluble. SMILES: C[C@@H]1C[C@H](OC(C(C([2H])([2H])[2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)[C@@]2([H])C(C=C[C@H](C)[C@@H]2CC[C@@H]3C[C@@H](O)CC(O3)=O)=C1. InChi Code: InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1/i1D3,3D3,5D2,15D. InChi Key: PCZOHLXUXFIOCF-LPWHJBMXSA-N. Origin: Synthetic.